{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T00:09:31Z","timestamp":1790726971652,"version":"4.1.0"},"reference-count":10,"publisher":"Oxford University Press (OUP)","issue":"5","license":[{"start":{"date-parts":[[2026,7,28]],"date-time":"2026-07-28T00:00:00Z","timestamp":1785196800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100009032","name":"Pfizer Ltd UK","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009032","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,9,30]]},"abstract":"<jats:p>Alopecia areata (AA) and atopic dermatitis (AD) are both chronic inflammatory conditions, associated with physical and significant psychosocial burden, with patients facing considerable barriers to care in the UK. In this perspective, we explore gaps in care in the UK healthcare system for patients with AA and AD, gaining insights from healthcare professionals, patients and patient advocates to identify opportunities for improvement within primary care and secondary care.<\/jats:p>","DOI":"10.1093\/skinhd\/vzag117","type":"journal-article","created":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T11:42:32Z","timestamp":1783424552000},"page":"838-842","source":"Crossref","is-referenced-by-count":0,"title":["Identifying and addressing obstacles to optimal alopecia areata and atopic dermatitis care in the UK"],"prefix":"10.1093","volume":"6","author":[{"given":"Stephanie","family":"Gallard","sequence":"first","affiliation":[{"name":"Liverpool University Hospitals FT Dermatology GPSI for the Liverpool ICATS, , Liverpool ,","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sue","family":"Schilling","sequence":"additional","affiliation":[{"name":"Alopecia UK , Shipley ,","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suzi","family":"Holland","sequence":"additional","affiliation":[{"name":"Eczema Outreach Support , Linlithgow ,","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Megan","family":"Mowbray","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Queen Margaret Hospital , Dunfermline ,","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sophia","family":"Conner","sequence":"additional","affiliation":[{"name":"West Glasgow Ambulatory Care Hospital, NHS Greater Glasgow and Clyde Department of Dermatology,\u00a0 , Glasgow ,","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manjit","family":"Kaur","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Solihull Hospital, University Hospitals Birmingham NHS Foundation Trust , Solihull ,","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yousaf","family":"Aftab","sequence":"additional","affiliation":[{"name":"Pfizer Ltd , Walton Oaks ,","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benoit","family":"Raymond","sequence":"additional","affiliation":[{"name":"Pfizer Ltd , Walton Oaks ,","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gulraj","family":"Matharu","sequence":"additional","affiliation":[{"name":"Pfizer Ltd , Walton Oaks ,","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karim","family":"Amer","sequence":"additional","affiliation":[{"name":"Pfizer Ltd , Walton Oaks ,","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kave","family":"Shams","sequence":"additional","affiliation":[{"name":"Dermatology Department, The Leeds Teaching Hospitals NHS Trust , Leeds ,","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0049-8377","authenticated-orcid":false,"given":"Leila","family":"Asfour","sequence":"additional","affiliation":[{"name":"Dermatology Department, Chelsea and Westminster NHS Foundation Trust , London ,","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2026,7,28]]},"reference":[{"key":"2026092919520107900_vzag117-B1","author":"Levell N"},{"key":"2026092919520107900_vzag117-B2","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1093\/bjd\/ljae385","article-title":"British Association of Dermatologists living guideline for managing people with alopecia areata 2024","volume":"192","author":"Harries","year":"2025","journal-title":"Br J Dermatol"},{"key":"2026092919520107900_vzag117-B3","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1093\/bjd\/ljae307","article-title":"Lifetime incidence and healthcare disparities in alopecia areata: a UK population-based cohort study","volume":"191","author":"Thompson","year":"2024","journal-title":"Br J Dermatol"},{"key":"2026092919520107900_vzag117-B4","doi-asserted-by":"crossref","first-page":"936","DOI":"10.3390\/life11090936","article-title":"The epidemiology and global burden of atopic dermatitis: a narrative review","volume":"11","author":"Hadi","year":"2021","journal-title":"Life"},{"key":"2026092919520107900_vzag117-B5","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1111\/bjd.21055","article-title":"The associated burden of mental health conditions in alopecia areata: a population-based study in UK primary care","volume":"187","author":"Macbeth","year":"2022","journal-title":"Br J Dermatol"},{"key":"2026092919520107900_vzag117-B6","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.1007\/s13555-023-00941-z","article-title":"The invisible impact of a visible disease: psychosocial impact of alopecia areata","volume":"13","author":"Mesinkovska","year":"2023","journal-title":"Dermatol Ther"},{"key":"2026092919520107900_vzag117-B7","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1007\/s13555-020-00459-8","article-title":"The economic and psychosocial comorbidity burden among adults with moderate-to-severe atopic dermatitis in Europe: analysis of a cross-sectional survey","volume":"11","author":"Girolomoni","year":"2021","journal-title":"Dermatol Ther"},{"key":"2026092919520107900_vzag117-B8","doi-asserted-by":"crossref","first-page":"8844","DOI":"10.1038\/s41598-024-59162-9","article-title":"Interventions for anxiety and depression in patients with atopic dermatitis: a systematic review and meta-analysis","volume":"14","author":"Hartono","year":"2024","journal-title":"Sci Rep"},{"key":"2026092919520107900_vzag117-B9","author":"Compufile Systems Ltd"},{"key":"2026092919520107900_vzag117-B10","author":"NHS England"}],"container-title":["Skin Health and Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/skinhd\/article-pdf\/6\/5\/838\/70284182\/vzag117.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/skinhd\/article-pdf\/6\/5\/838\/70284182\/vzag117.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T23:52:09Z","timestamp":1790725929000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/skinhd\/article\/6\/5\/838\/8746197"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,28]]},"references-count":10,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2026,7,28]]},"published-print":{"date-parts":[[2026,9,30]]}},"URL":"https:\/\/doi.org\/10.1093\/skinhd\/vzag117","relation":{},"ISSN":["2690-442X"],"issn-type":[{"value":"2690-442X","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,10]]},"published":{"date-parts":[[2026,7,28]]}}}